Mark G. Lewis

Active 1983–2025

140
Papers
26,339
Citations
79
h-index
133
i10-index

Citations

Citations per year for Mark G. Lewis1984: 2 citations1985: 2 citations1986: 1 citations1987: 1 citations1988: 1 citations1989: 1 citations1990: 1 citations1992: 4 citations1993: 2 citations1994: 3 citations1995: 7 citations1996: 5 citations1997: 6 citations1998: 4 citations1999: 5 citations2000: 18 citations2001: 97 citations2002: 155 citations2003: 109 citations2004: 154 citations2005: 140 citations2006: 153 citations2007: 116 citations2008: 110 citations2009: 99 citations2010: 96 citations2011: 115 citations2012: 105 citations2013: 86 citations2014: 86 citations2015: 117 citations2016: 125 citations2017: 243 citations2018: 250 citations2019: 557 citations2020: 1,099 citations2021: 2,453 citations2022: 1,870 citations2023: 862 citations2024: 1,013 citations2025: 425 citations2026: 12 citations1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,097 citing papers, 34.9% of this breakdownChina: 966 citing papers, 8.2% of this breakdownUnited Kingdom: 751 citing papers, 6.4% of this breakdownGermany: 484 citing papers, 4.1% of this breakdownCanada: 409 citing papers, 3.5% of this breakdownFrance: 404 citing papers, 3.5% of this breakdownAustralia: 321 citing papers, 2.7% of this breakdownNetherlands: 275 citing papers, 2.4% of this breakdownItaly: 269 citing papers, 2.3% of this breakdownIndia: 267 citing papers, 2.3% of this breakdownJapan: 262 citing papers, 2.2% of this breakdownSwitzerland: 222 citing papers, 1.9% of this breakdown
0%34.9%Other 25.6%

Fields

  • Medicine55.6%
  • Immunology and Microbiology25.1%
  • Biochemistry, Genetics and Molecular Biology11%
  • Computer Science4.6%
  • Engineering0.8%
  • Environmental Science0.5%
  • Other2.4%

Topics

  • SARS-CoV-2 and COVID-19 Research14%
  • COVID-19 Clinical Research Studies7.1%
  • HIV Research and Treatment7%
  • Immunotherapy and Immune Responses3.7%
  • Immune Cell Function and Interaction3.6%
  • vaccines and immunoinformatics approaches3%
  • Other61.6%

Coauthors

All papers

Open in search
  1. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katalin Karikó, Sampa Santra, Barney S. Graham, Mark G. Lewis, Theodore C. Pierson, Barton F. Haynes, Drew Weissman - Nature 2017 cited by 894

  2. Correlates of protection against SARS-CoV-2 in rhesus macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,238

  3. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas D. Madden, Michael J. Hope, Mark G. Lewis, Kelly K. Lee, Shiu‐Lok Hu, Scott E. Hensley, Michael P. Cancro, Barton F. Haynes, Drew Weissman - The Journal of Experimental Medicine 2018 cited by 527

  4. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2022 cited by 283

  5. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurent Pessaint, Alex Van Ry, Shanai Browne, Jack Greenhouse, Tammy Taylor, Amanda Strasbaugh, Tracey-Ann Campbell, Anthony Cook, Alan Dodson, Katelyn Steingrebe, Wei Shi, Yi Zhang, Olubukola M. Abiona, Lingshu Wang, Amarendra Pegu, Eun Sung Yang, Kwanyee Leung, Tongqing Zhou, I‐Ting Teng, Alicia T. Widge, Ingelise J. Gordon, Laura Novik, Rebecca A. Gillespie, Rebecca J. Loomis, Juan I. Moliva, Guillaume B. E. Stewart-Jones, Sunny Himansu, Wing‐Pui Kong, Martha Nason, Kaitlyn M. Morabito, Tracy J. Ruckwardt, Julie E. Ledgerwood, Martin R. Gaudinski, Peter D. Kwong, John R. Mascola, Andrea Carfı́, Mark G. Lewis, Ralph S. Baric, Adrian B. McDermott, Ian N. Moore, Nancy J. Sullivan, Mario Roederer, Robert A. Seder, Barney S. Graham - New England Journal of Medicine 2020 cited by 1,174

  6. Animal models for COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ivana Knežević, Philip R. Krause, Jens H. Kuhn, Roger Le Grand, Mark G. Lewis, Wen‐Chun Liu, Pauline Maisonnasse, Anita K. McElroy, Vincent J. Munster, Nadia Oreshkova, Angela L. Rasmussen, Joana Rocha‐Pereira, Barry Rockx, Estefanía Rodríguez, Thomas F. Rogers, Francisco J. Salguero, Michael Schotsaert, Koert J. Stittelaar, Hendrik Jan Thibaut, Chien‐Te K. Tseng, Júlia Vergara‐Alert, Martin Beer, Trevor Brasel, Jasper Fuk‐Woo Chan, Adolfo García‐Sastre, Johan Neyts, Stanley Perlman, Douglas S. Reed, Jüergen A. Richt, Chad J. Roy, Joaquím Segalés, Seshadri S. Vasan, Ana María Henao-Restrepo, Dan H. Barouch - Nature 2020 cited by 880

  7. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack Greenhouse, Swagata Kar, Laurent Pessaint, Maciel Porto, Katelyn Steingrebe, Daniel Valentin, Serge Zouantcha, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Renee van de Wetering, Seyhan Boyoglu-Barnum, Kwanyee Leung, Wei Shi, Eun Sung Yang, Yi Zhang, John-Paul Todd, Lingshu Wang, Gabriela Alvarado, Hanné Andersen, Kathryn E. Foulds, Darin K. Edwards, John R. Mascola, Ian N. Moore, Mark G. Lewis, Andrea Carfı́, David C. Montefiori, Mehul S. Suthar, Adrian B. McDermott, Mario Roederer, Nancy J. Sullivan, Daniel C. Douek, Barney S. Graham, Robert A. Seder - Science 2021 cited by 329

  8. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19

    Authors: , , , , , , , , , , , , , - Nature Nanotechnology 2021 cited by 172

  9. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2022 cited by 140

  10. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ralph S. Baric, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch - Nature 2021 cited by 133

  11. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2023 cited by 96

  12. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura L. Sutherland, David C. Montefiori, Robert J. Edwards, Kevin O. Saunders, Charlene McDanal, Giovanna E. Hernandez, Katayoun Mansouri, Robert E. Parks, Xiaozhi Lu, Blake M. Hauser, C. Todd DeMarco, Fangping Cai, Barney S. Graham, Kevin Wiehe, John R. Mascola, Gregory D. Sempowski, Hanné Andersen, Elizabeth Petzold, David R. Martinez, Peter D. Kwong, Victoria Gee-Lai, Megan Kopp, S. Gobeil, Victoria Stalls, Aja Sanzone, Wes Rountree, Barton F. Haynes, Mark G. Lewis, Priyamvada Acharya, Thomas H. Oguin, Chuancang Jiang, I‐Ting Teng, Andrew Foulger, Christopher W. Woods - Cell 2021 cited by 334

  13. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

    Authors: , , , , , , , , , , , , , , , , , - Nature Microbiology 2021 cited by 421

  14. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas H. Oguin, Gregory D. Sempowski, Matthew Gagné, Daniel C. Douek, Mark A. Tomai, Christopher B. Fox, Robert A. Seder, Kevin Wiehe, Drew Weissman, Norbert Pardi, Hana Golding, Surender Khurana, Priyamvada Acharya, Hanné Andersen, Mark G. Lewis, Ian N. Moore, David C. Montefiori, Ralph S. Baric, Barton F. Haynes - Nature 2021 cited by 276

  15. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manoj S. Nair, Vincent Dussupt, Sharon P. Daye, Xiankun Zeng, Erica K. Barkei, Hilary Staples, Kendra J. Alfson, Ricardo Carrion, Shelly J. Krebs, Dominic Paquin‐Proulx, Nicos Karasavva, Victoria R. Polonis, Linda L. Jagodzinski, Mihret F. Amare, Sandhya Vasan, Paul T. Scott, Yaoxing Huang, David D. Ho, Natalia de Val, Michael Diamond, Mark G. Lewis, Mangala Rao, Gary R. Matyas, Gregory D. Gromowski, Sheila A. Peel, Nelson L. Michael, Diane L. Bolton, Kayvon Modjarrad - Science Translational Medicine 2022 cited by 145

  16. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Valentin, Anthony Cook, Alan Dodson, Katelyn Steingrebe, Saule Nurmukhambetova, Sucheta Godbole, Amy R. Henry, Farida Laboune, Jesmine Roberts-Torres, Cynthia G. Lorang, Shivani Amin, Jessica F. Trost, Mursal Naisan, Manjula Basappa, Jacquelyn Willis, Lingshu Wang, Wei Shi, Nicole A. Doria‐Rose, Yi Zhang, Eun Sung Yang, Kwanyee Leung, Sijy O’Dell, Stephen D. Schmidt, Adam S. Olia, Cuiping Liu, Darcy R. Harris, Gwo‐Yu Chuang, Guillaume B. E. Stewart-Jones, Isabella Renzi, Yen‐Ting Lai, Agata Malinowski, Kaichun Wu, John R. Mascola, Andrea Carfı́, Peter D. Kwong, Darin K. Edwards, Mark G. Lewis, Hanné Andersen, Kizzmekia S. Corbett, Martha Nason, Adrian B. McDermott, Mehul S. Suthar, Ian N. Moore, Mario Roederer, Nancy J. Sullivan, Daniel C. Douek, Robert A. Seder - Cell 2022 cited by 228

  17. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

    Authors: , , , , , , , , , , - Nature Medicine 2010 cited by 495

  18. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Makda S. Gebre, Emily Hoffman, Catherine Jacob-Dolan, Marinela Kirilova, Zhenfeng Li, Zijin Lin, Shant H. Mahrokhian, Lori F. Maxfield, Felix Nampanya, Ramya Nityanandam, Joseph P. Nkolola, Shivani Patel, John D. Ventura, Kaylee Verrington, Huahua Wan, Laurent Pessaint, Alex Van Ry, Kelvin Blade, Amanda Strasbaugh, Mehtap Cabus, Renita Brown, Anthony Cook, Serge Zouantchangadou, Elyse Teow, Hanné Andersen, Mark G. Lewis, Yongfei Cai, Bing Chen, Aaron G. Schmidt, R. Keith Reeves, Ralph S. Baric, Douglas A. Lauffenburger, Galit Alter, Paul Stoffels, Mathai Mammen, Johan Van Hoof, Hanneke Schuitemaker, Dan H. Barouch - Nature 2020 cited by 907

  19. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 635

  20. Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2018 cited by 319

  21. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Derek W. Cain, Mattia Bonsignori, David C. Montefiori, Frederick W. Alt, Barton F. Haynes - Science 2019 cited by 184

  22. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2013 cited by 643

  23. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanné Andersen, Mark G. Lewis, Neil Stahl, Andrew Murphy, George D. Yancopoulos, Christos A. Kyratsous - Science 2020 cited by 588

  24. Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert W. Doms, David C. Montefiori, Barton F. Haynes, Joseph Sodroski, Peter D. Kwong, Beatrice H. Hahn, George M. Shaw - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 239